BESREMI

Welcome to the Brand page for “BESREMI”, which is offered here for Immunostimulants; pre-filled syringes containing pegylated interferons for medical purposes; anticancer pharmaceuticals; medicines for human purposes of treating cancers, polycythemia vera (pv) and other myeloproliferative neoplasms (mpns); western medicine, ropeginterferon alfa-2b; active pharmaceutical ingredients for active pharmaceutical ingredients of ropeginterferon alfa-2b for treating cancers, pv and other mpns; medicinal agent for human use, pharmaceuticals for treating cancers or viral infections; biological preparations for medical purposes, ropeginterferon alfa-2b; chemical preparations for medical purposes, for cancers, pv and other mpns; chemical-pharmaceutical preparations, for treating cancers, pv and other mpns; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes, for treating cancers, pv and other mpns; pharmaceutical preparations for treating cancers, pv and other mpns;.

Its status is currently believed to be active. Its class is unavailable. “BESREMI” is believed to be currently owned by “PharmaEssentiA Corporation”.


Owner:
PHARMAESSENTIA CORPORATION
Owner Details
Description:
Immunostimulants; pre-filled syringes containing PEGylated interferons for medical purposes; anticancer pharmaceuticals; medicines for human purposes of treating cancers, polycythemia vera (PV) and other myeloproliferative neoplasms (MPNs); western medicine, ropeginterferon alfa-2b; active pharmaceutical ingredients for active pharmaceutical ingredients of ropeginterferon alfa-2b for treating cancers, PV and other MPNs; medicinal agent for human use, pharmaceuticals for treating cancers or viral infections; biological preparations for medical purposes, ropeginterferon alfa-2b; chemical preparations for medical purposes, for cancers, PV and other MPNs; chemical-pharmaceutical preparations, for treating cancers, PV and other MPNs; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes, for treating cancers, PV and other MPNs; pharmaceutical preparations for treating cancers, PV and other MPNs;
Categories: IMMUNOSTIMULANTS